# Reliable Med

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reliable-med

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.reliablemed.cn
- Total disclosed funding: $15M
- Latest round: Series A (Feb 6, 2023)
- Investors on record: 8

## About

Founded in 2019 and based in Hangzhou, China, Reliable Med is a medical equipment company that focuses on R&D, production, and sales of mass spectrometry equipment and related kits. The company launched ICP-Mass Spectrometry (ICP-MS) in March 2020 and received Medical device registration certification in April 2021. In July 2020, the company launched a mass spectrometry autosampler, Sample ET60. The company has two R&D centers in Hangzhou, and Suzhou, and has a 9,800 square meters factory. Moreover, the company has patents and software rights for over 100 items. And the company has many honors, such as National High-tech Enterprise, Hangzhou Young Eagle Plan Enterprise.

The company provides mass spectrometry equipment, including inorganic mass spectrometry devices, and organic mass spectrometry devices. The inorganic mass spectrometry device, Inspector SQ60, is also named trace elemental analyzer, which supports testing trace elements in the human body based on the sample of blood or urine. As of March 2022, the inorganic mass spectrometry device sells to more than 20 provinces and cities in China, and cooperates with 3A grade hospitals and third-party testing institutions. The company also provides medical testing services.

The company generates revenues from sales of mass spectrometry equipment and related kits.  In September 2025, Reliable Med closed a venture funding from new investor Hangzhou Gongshu District Industrial Investment.

## Funding rounds

- Series A, Feb 6, 2023, $15M — Suzhou Trust, Industrial Securities Capital
- Series A, Feb 24, 2022 — Legend Capital, CPE Funds Management, CD Capital, Hangzhou Xiaochi Private Equity Fund Management
- Series A, May 31, 2021 — Legend Capital, Huagai Capital, CD Capital, 3H Health Investment
- Series A, Dec 18, 2020 — Legend Capital, Huagai Capital, CD Capital

## Investors

- Legend Capital — Series A
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series A
- CD Capital — Series A
- 3H Health Investment (https://capitalatlas.ai/funds/3h-health-investment) — Series A
- CPE Funds Management (https://capitalatlas.ai/funds/cpe-funds-management) — Series A
- Hangzhou Xiaochi Private Equity Fund Management (https://capitalatlas.ai/funds/hangzhou-xiaochi-private-equity-fund-management) — Series A
- Suzhou Trust — Series A
- Industrial Securities Capital — Series A